Absorption rate limit considerations for oral phosphate prodrugs.
Heimbach T, Oh DM, Li LY, Forsberg M, Savolainen J, Leppänen J, Matsunaga Y, Flynn G, Fleisher D.
Heimbach T, et al. Among authors: fleisher d.
Pharm Res. 2003 Jun;20(6):848-56. doi: 10.1023/a:1023827017224.
Pharm Res. 2003.
PMID: 12817887
Free article.